Acute myeloid leukemia (AML) is an aggressive cancer affecting the blood and bone marrow that progresses rapidly, making immediate treatment essential.
Epigenetic enzyme SETD1B drives aggressive growth in acute myeloid leukemia
- Post author:admin
- Post published:June 26, 2025
- Post category:uncategorized